U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Approval Year

Unknown
149124
Substance Class Protein
Created
by admin
on Wed Apr 02 00:32:27 GMT 2025
Edited
by admin
on Wed Apr 02 00:32:27 GMT 2025
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
YGF9TW3QZJ
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ABBV-323
Preferred Name English
RAVAGALIMAB
INN  
Official Name English
ravagalimab [INN]
Common Name English
IMMUNOGLOBULIN G1, (ANTI-HUMAN CD19 (ANTIGEN)) (HUMANIZED CLONE RB4V1.2 .GAMMA.1-CHAIN), DISULFIDE WITH HUMANIZED CLONE RB4V1.2 .KAPPA.-CHAIN, DIMER
Systematic Name English
RAVAGALIMAB [USAN]
Common Name English
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 5 (B-CELL SURFACE ANTIGEN CD40))HUMANIZED MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN (1-446) (HUMANIZED VH (HOMO SAPIENS IGHV3-48*01 (90%) (IGHD)-IGHJ6*01) (8.8.9)
Systematic Name English
PR-1629977
Code English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD40 ANTIGEN) (HUMANIZED MOUSE MONOCLONAL PR-1629977 .GAMMA.1-CHAIN), DISULFIDE WITH HUMANIZED MOUSE MONOCLONAL PR-1629977 .KAPPA.-CHAIN, DIMER
Common Name English
Code System Code Type Description
NCI_THESAURUS
C170363
Created by admin on Wed Apr 02 00:32:27 GMT 2025 , Edited by admin on Wed Apr 02 00:32:27 GMT 2025
PRIMARY
INN
10750
Created by admin on Wed Apr 02 00:32:27 GMT 2025 , Edited by admin on Wed Apr 02 00:32:27 GMT 2025
PRIMARY
USAN
GH-77
Created by admin on Wed Apr 02 00:32:27 GMT 2025 , Edited by admin on Wed Apr 02 00:32:27 GMT 2025
PRIMARY
SMS_ID
100000178328
Created by admin on Wed Apr 02 00:32:27 GMT 2025 , Edited by admin on Wed Apr 02 00:32:27 GMT 2025
PRIMARY
CAS
2050816-56-1
Created by admin on Wed Apr 02 00:32:27 GMT 2025 , Edited by admin on Wed Apr 02 00:32:27 GMT 2025
PRIMARY
FDA UNII
YGF9TW3QZJ
Created by admin on Wed Apr 02 00:32:27 GMT 2025 , Edited by admin on Wed Apr 02 00:32:27 GMT 2025
PRIMARY
From To
1_22 1_96
1_143 1_199
1_260 1_320
1_366 1_424
2_22 2_96
2_143 2_199
2_260 2_320
2_366 2_424
1_225 2_225
1_228 2_228
1_219 3_220
2_219 4_220
3_23 3_94
3_140 3_200
4_23 4_94
4_140 4_200
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_296
N 2_296
Related Record Type Details
TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 5
TARGET -> INHIBITOR
Related Record Type Details
RAVAGALIMAB
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
Molecular Formula CHEMICAL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966